Health Information on the Web
3-7-2017Editor’s Note: It is important to have up-to-date information on health - learn what our colleagues at FDA have to say about finding up-to-date health informa…
Food & Drug Administration
FDA Seeks Public Comment on Blood Donor Deferral Policy
8-1-2016Editor's Note: Here is a guest blog from the Food and Drug Administration (FDA).
On July 26, 2016, the Food and Drug Administration (FDA) issued a notice in th…
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection
6-30-2016First regimen to treat all six major HCV genotypesThe U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus …
FDA Launches Campaign that Affirms LGBT Young Adults' Freedom to Be, Tobacco Free
5-11-2016Last week, I had the privilege of participating in the launch of “This Free Life,” the Food and Drug Administration’s (FDA) new anti-smoking c…
FDA Issues Revised Draft Guidance on Developing New Hep C Treatments
5-6-2016FDA has revised a draft guidance, titled Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment. The purpose of the guidanc…
Califf, FDA top officials call for sweeping review of agency opioids policies
2-5-2016Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among perso…
FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4
2-2-2016The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C viru…
FDA updates blood donor deferral policy to reflect the most current scientific evidence and continue to ensure the safety of the U.S. blood supply
12-21-2015Today, the U.S. Food and Drug Administration issued final guidance outlining updated blood donor deferral recommendations to reflect the most current scientific…
FDA Issues Final Industry Guidance for Developing Antiretroviral Drugs for HIV Treatment
11-13-2015This week, FDA announced the availability of a final guidance for industry entitled “Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral D…
FDA approves new treatment for HIV
11-10-2015The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir …